High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample-Reference-Cited by-同舟云学术

High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample

Published:1992-11 Issue:1 Volume:583 Page:83-90
ISSN:0378-4347
Container-title:Journal of Chromatography B: Biomedical Sciences and Applications
language:en
Short-container-title:Journal of Chromatography B: Biomedical Sciences and Applications

Author:

Lennard Lynne,Singleton Helen J.

Publisher

Elsevier BV

Subject

General Chemistry

Reference13 articles.

1. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.

2. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

3. Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells

4. Assay of 6-mercaptopurine in human plasma

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy;Clinical Pharmacokinetics;2024-07-20

2. Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol;Hepatology;2024-05-29

3. Monitoring of azathioprine metabolite concentrations and cytokine levels in neuromyelitis optica spectrum disorder;2023-06-12

4. Comparison of the use of 6-thioguanine riboside versus 6-thioguanine as calibration standard to monitor 6-thioguanine nucleotides in red blood cells;Journal of Pharmaceutical and Biomedical Analysis Open;2023-06

5. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy;Digestive Diseases and Sciences;2023-05-02